255 related articles for article (PubMed ID: 8258711)
1. Mycobacteria-macrophage interactions. Macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages.
Stokes RW; Haidl ID; Jefferies WA; Speert DP
J Immunol; 1993 Dec; 151(12):7067-76. PubMed ID: 8258711
[TBL] [Abstract][Full Text] [Related]
2. Nonopsonic and opsonic association of Mycobacterium tuberculosis with resident alveolar macrophages is inefficient.
Stokes RW; Thorson LM; Speert DP
J Immunol; 1998 Jun; 160(11):5514-21. PubMed ID: 9605155
[TBL] [Abstract][Full Text] [Related]
3. Lipoarabinomannan inhibits nonopsonic binding of Mycobacterium tuberculosis to murine macrophages.
Stokes RW; Speert DP
J Immunol; 1995 Aug; 155(3):1361-9. PubMed ID: 7636201
[TBL] [Abstract][Full Text] [Related]
4. Utilization of CD11b knockout mice to characterize the role of complement receptor 3 (CR3, CD11b/CD18) in the growth of Mycobacterium tuberculosis in macrophages.
Melo MD; Catchpole IR; Haggar G; Stokes RW
Cell Immunol; 2000 Oct; 205(1):13-23. PubMed ID: 11078603
[TBL] [Abstract][Full Text] [Related]
5. Dissimilar and similar functional properties of complement receptor-3 in microglia and macrophages in combating yeast pathogens by phagocytosis.
Hadas S; Reichert F; Rotshenker S
Glia; 2010 May; 58(7):823-30. PubMed ID: 20091776
[TBL] [Abstract][Full Text] [Related]
6. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors.
Schlesinger LS
J Immunol; 1993 Apr; 150(7):2920-30. PubMed ID: 8454864
[TBL] [Abstract][Full Text] [Related]
7. The receptor-mediated uptake, survival, replication, and drug sensitivity of Mycobacterium tuberculosis within the macrophage-like cell line THP-1: a comparison with human monocyte-derived macrophages.
Stokes RW; Doxsee D
Cell Immunol; 1999 Oct; 197(1):1-9. PubMed ID: 10555990
[TBL] [Abstract][Full Text] [Related]
8. Absence of complement receptor 3 results in reduced binding and ingestion of Mycobacterium tuberculosis but has no significant effect on the induction of reactive oxygen and nitrogen intermediates or on the survival of the bacteria in resident and interferon-gamma activated macrophages.
Rooyakkers AW; Stokes RW
Microb Pathog; 2005 Sep; 39(3):57-67. PubMed ID: 16084683
[TBL] [Abstract][Full Text] [Related]
9. Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products.
Rojas M; Barrera LF; Puzo G; Garcia LF
J Immunol; 1997 Aug; 159(3):1352-61. PubMed ID: 9233632
[TBL] [Abstract][Full Text] [Related]
10. [Differential growth inhibition of mycobacteria by interferon-gamma-or tumor necrosis factor-alpha-treated murine peritoneal macrophages].
Sato K; Tomioka H; Saito H
Kekkaku; 1996 Nov; 71(11):607-14. PubMed ID: 8958673
[TBL] [Abstract][Full Text] [Related]
11. Complement receptor type three-dependent degradation of opsonized erythrocytes by mouse macrophages.
Rothlein R; Springer TA
J Immunol; 1985 Oct; 135(4):2668-72. PubMed ID: 3897377
[TBL] [Abstract][Full Text] [Related]
12. The mouse macrophage receptor for C3bi (CR3) is a major mechanism in the phagocytosis of Leishmania promastigotes.
Mosser DM; Edelson PJ
J Immunol; 1985 Oct; 135(4):2785-9. PubMed ID: 3161950
[TBL] [Abstract][Full Text] [Related]
13. CD44 is a macrophage binding site for Mycobacterium tuberculosis that mediates macrophage recruitment and protective immunity against tuberculosis.
Leemans JC; Florquin S; Heikens M; Pals ST; van der Neut R; Van Der Poll T
J Clin Invest; 2003 Mar; 111(5):681-9. PubMed ID: 12618522
[TBL] [Abstract][Full Text] [Related]
14. Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages.
Zimmerli S; Edwards S; Ernst JD
Am J Respir Cell Mol Biol; 1996 Dec; 15(6):760-70. PubMed ID: 8969271
[TBL] [Abstract][Full Text] [Related]
15. Macrophage--Mycobacterium tuberculosis interactions: role of complement receptor 3.
Velasco-Velázquez MA; Barrera D; González-Arenas A; Rosales C; Agramonte-Hevia J
Microb Pathog; 2003 Sep; 35(3):125-31. PubMed ID: 12927520
[TBL] [Abstract][Full Text] [Related]
16. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.
Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD
J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505
[TBL] [Abstract][Full Text] [Related]
17. Phagocytosis by human monocyte-derived macrophages. Independent function of receptors for C3b (CR1) and iC3b (CR3).
Newman SL; Devery-Pocius JE; Ross GD; Henson PM
Complement; 1984; 1(4):213-27. PubMed ID: 6242391
[TBL] [Abstract][Full Text] [Related]
18. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages.
Ferguson JS; Voelker DR; McCormack FX; Schlesinger LS
J Immunol; 1999 Jul; 163(1):312-21. PubMed ID: 10384130
[TBL] [Abstract][Full Text] [Related]
19. Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells.
Cywes C; Godenir NL; Hoppe HC; Scholle RR; Steyn LM; Kirsch RE; Ehlers MR
Infect Immun; 1996 Dec; 64(12):5373-83. PubMed ID: 8945590
[TBL] [Abstract][Full Text] [Related]
20. Murine macrophages lack expression of the Cr2-145 (CR2) and Cr2-190 (CR1) gene products.
Martin BK; Weis JH
Eur J Immunol; 1993 Nov; 23(11):3037-42. PubMed ID: 7693486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
